Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 32 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

32 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Aug. 26, 2022 ARRY P 7,000 $21.66 $151,620 41,269 Direct +20.43% Acquired -82.0% (price as of 2026-10-05)
Aug. 25, 2021 ARRY P 10,200 $19.01 $193,902 10,200 Direct · Acquired -79.5% (price as of 2026-10-05)
March 16, 2021 DBD S 9,412 $17.11 $161,039 564,336 Direct -1.64% Disposed 284.7% (price as of 2026-10-06)
March 16, 2021 DBD S 53,636 $16.39 $879,094 573,748 Direct -8.55% Disposed 301.6% (price as of 2026-10-06)
March 16, 2021 DBD S 9,412 $17.11 $161,039 564,336 Direct -1.64% Disposed 284.7% (price as of 2026-10-06)
March 16, 2021 DBD S 53,636 $16.39 $879,094 573,748 Direct -8.55% Disposed 301.6% (price as of 2026-10-06)
March 15, 2021 DBD S 39,449 $17.15 $676,550 627,384 Direct -5.92% Disposed 283.8% (price as of 2026-10-06)
March 15, 2021 DBD S 39,449 $17.15 $676,550 627,384 Direct -5.92% Disposed 283.8% (price as of 2026-10-06)
March 6, 2020 DBD P 10,000 $5.69 $56,900 578,856 Direct +1.76% Acquired 1056.8% (price as of 2026-10-06)
Oct. 31, 2019 DBD P 28,000 $6.94 $194,320 518,070 Direct +5.71% Acquired 848.4% (price as of 2026-10-06)
March 4, 2019 DBD P 22,222 $8.80 $195,554 490,070 Direct +4.75% Acquired 648.0% (price as of 2026-10-06)
May 8, 2018 DBD P 10,000 $11.85 $118,500 10,000 Indirect · Acquired 455.4% (price as of 2026-10-06)
May 4, 2018 DBD P 8,300 $11.80 $97,940 117,245 Direct +7.62% Acquired 457.8% (price as of 2026-10-06)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
May 19, 2026 ARRY Restricted Stock Units Common Stock, par value $0.001 per share (22,164) · · 22,164 Disposed
May 19, 2026 ARRY Restricted Stock Units Common Stock, par value $0.001 per share (22,641) · · 22,641 Acquired
May 20, 2025 ARRY Restricted Stock Units Common Stock, par value $0.001 per share (22,164) · · 22,164 Acquired
Jan. 30, 2020 DBD Non-Qualified Stock Option [F4] Common Shares (253,907) · Jan. 30, 2030 253,907 Acquired
Jan. 30, 2020 DBD Non-Qualified Stock Option [F4] Common Shares (253,907) $11.96 Jan. 30, 2030 253,907 Acquired
April 25, 2019 DBD Performance Share Units Common Shares (56,059) · April 25, 2022 56,059 Acquired
April 25, 2019 DBD Non-Qualified Stock Option [F3] Common Shares (34,678) $13.98 April 25, 2029 34,678 Acquired
Jan. 29, 2019 DBD Non-Qualified Stock Option [F4] Common Shares (676,814) $4.49 Jan. 29, 2029 676,814 Acquired
Feb. 21, 2018 DBD Non-Qualified Stock Option [F3] Common Shares (192,049) $15.35 Feb. 20, 2028 192,049 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

DBD

CEO
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2022 · · · · · · $4,072,158 $4,291,389
2021 · · · · $3,063,679 · $51,643 $26,169,529
2020 · · · · $1,133,160 · $55,637 $5,312,150

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.